[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Belinostat is a histone deacetylase inhibitor with anti-tumor effect in several pre-clinical tumor models and clinical trials. The aim of the study was to evaluate changes in cell proliferation and glucose uptake by use of 3'-deoxy-3'-[(18)F]fluorothymidine ([18F]FLT) and 2-deoxy-2-[(18)F]fluoro-D-glucose ([18F]FDG) positron emission tomography (PET) following treatment with belinostat in ovarian cancer in vivo models.
Originalsprog | Engelsk |
---|---|
Artikelnummer | 168 |
Tidsskrift | B M C Cancer |
Vol/bind | 13 |
Sider (fra-til) | 1-9 |
Antal sider | 10 |
ISSN | 1471-2407 |
DOI | |
Status | Udgivet - 2013 |
ID: 45864120